Changeflow GovPing Healthcare & Life Sciences Patent Application for Artemisinic Acid Derivat...
Routine Notice Added Draft

Patent Application for Artemisinic Acid Derivative Preparation

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO has published a patent application (US20260085030A1) for an artemisinic acid derivative and its preparation method. The application, filed by Yunnan Botanee Bio-Technology Group Co., Ltd., aims to improve the water solubility of artemisinic acid and dihydroartemisinic acid while retaining their whitening, anti-inflammatory, and anti-tumor properties.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a published patent application from the USPTO detailing a new artemisinic acid derivative. The invention focuses on creating water-soluble forms of artemisinic acid or dihydroartemisinic acid through reactions with organic compounds, peptides, or basic metal compounds. The application highlights the potential benefits of these derivatives, including improved solubility and combined biological activities such as whitening, anti-inflammatory, and anti-tumor effects, suggesting significant research and development prospects.

As this is a patent application, it does not impose immediate regulatory obligations on companies. However, it signals potential future developments in the pharmaceutical and cosmetic industries. Companies involved in the research, development, or manufacturing of artemisinic acid-based products, particularly those seeking improved formulations for topical or systemic applications, should monitor the progress of this patent application and related intellectual property.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

ARTEMISINIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Application US20260085030A1 Kind: A1 Mar 26, 2026

Assignee

Yunnan Botanee Bio-Technology Group Co., Ltd.

Inventors

Yichun WANG, Feifei WANG, Liping QU, Yanzhen SHEN, Zuding WANG, Qiongfen WU, Lijuan YAN, Zhaoxiang YANG, Xiao MA, Zhenyu GUO

Abstract

An artemisinic acid derivative includes: a water-soluble organic salt formed by a reaction of artemisinic acid or dihydroartemisinic acid with a small-molecule basic organic compound, or a water-soluble complex formed by a reaction of artemisinic acid or dihydroartemisinic acid with a small molecule peptide, or a water-soluble salt formed by a reaction of artemisinic acid or dihydroartemisinic acid with a basic metal compound. The artemisinic acid derivative provided by the present application solves the problem of difficulty in dissolving the artemisinic acid and the dihydroartemisinic acid in water, and combines whitening, anti-inflammatory, and anti-tumor biological activities, thus having a good research and development prospect.

CPC Classifications

C07C 57/26 A61K 8/0212 A61K 8/022 A61K 8/06 A61K 8/37 A61K 8/44 A61K 8/4926 A61K 8/64 A61K 9/107 A61K 9/19 A61K 31/19 A61K 31/198 A61K 31/455 A61K 31/4965 A61K 38/063 A61Q 1/00 C07C 51/41 C07C 51/418 C07C 51/47 C07C 229/26 C07C 279/14 C07D 213/82 C07D 241/12 C07F 1/00 C07F 1/04 C07C 2602/28

Filing Date

2025-10-28

Application No.

19372194

View original document →

Named provisions

Abstract Assignee Inventors

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
October 28th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085030A1

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Chemical Synthesis
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Drug Development

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!